TCL Archive In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations March 30, 1979
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In October 10, 2014